Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeOur CompanyOur societal impact Global Health Equity Why drug-resistant TB matters to the world
      Professor Madhukar Pai, Director of McGill Global Health Programs, speaking on camera during segment on efforts to combat drug-resistant tuberculosis

      Why drug-resistant TB matters to the world

      Share Article
      share to

      Beyond its devastating impact on human lives, DR-TB takes a tremendous economic toll. The EIU analysis shows that, based on current incidence and prevalence rates, DR-TB deaths in a single year are estimated to cost the global economy at least US $17.8 billion.

      Learn more about the report here.

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.